PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on ...

Total product sales -- $7.3 billion in fiscal Q3 2025, up 4% sequentially from Q2 2025, with growth driven by the HIV ...

Cambridge-based PACT raised investment in a Series A round to scale its sustainable biomaterial platform. Know more about it below.

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that Dupixent ® (dupilumab) has been recognized as the “Best Biotechnology Product” of 2025 by the Galien Foundation, which acknowledges ...

As drug development becomes more complex, so do the demands for accurate, reproducible bioanalytical data to prove their ...